Femtobiomed Inc. (XKON:327610)
South Korea · Delayed Price · Currency is KRW 1,668.00
+119.00 (7.68%)
At close: Nov 21, 2025
Femtobiomed Company Description
Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform.
The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research.
The company was founded in 2011 and is based in Seongnam-si, South Korea.
Femtobiomed Inc.
| Country | South Korea |
| Founded | 2011 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: D-510, 700, Pangyo-ro Seongnam-si, 13516 South Korea | |
| Phone | 82 3 1628 8158 |
| Website | femtobiomed.com |
Stock Details
| Ticker Symbol | 327610 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |